Journal article
Targeting vascular endothelial growth factor in renal cell carcinoma.
- Abstract:
-
Renal cancer is the most lethal of all urological malignancies with overall 5-year survival rates of around 60%. The predominant reason for the poor prognosis of this cancer has been the relative lack of effective systemic therapy for advanced metastatic disease. Until recently immunotherapy with interleukin-2 or interferon-alpha has been the standard of care for metastatic renal cell carcinoma (RCC); however, the response rates for these treatments were at best only 3-21%. The use of molecul...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
- Volume:
- 30
- Issue:
- 5-6
- Pages:
- 292-299
- Publication date:
- 2009-01-01
- DOI:
- EISSN:
-
1423-0380
- ISSN:
-
1010-4283
- Source identifiers:
-
315972
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:315972
- UUID:
-
uuid:4f4dde52-9034-46e4-b5c8-69eb5f19e182
- Local pid:
- pubs:315972
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record